AJP - Heart and Circulatory Physiology, Vol 271, Issue 3 1004-H1014, Copyright © 1996 by American Physiological Society

ARTICLES

Cardioprotection with ischemic preconditioning and MLA: role of adenosine-regulating enzymes?

K. Przyklenk, L. Zhao, R. A. Kloner and G. T. Elliott
Heart Institute, Good Samaritan Hospital, Los Angeles 90017-2395, USA.

Both ischemic preconditioning and pretreatment with the endotoxin derivative monophosphoryl lipid A (MLA) protect the heart against infarction, yet the cellular mechanisms responsible for the cardioprotection achieved with either intervention are unknown. Using pentobarbital-anesthetized dogs, we tested the hypothesis that increased activity of 5'-nucleotidase (5'-NT), the enzyme that catalyzes the formation of adenosine from AMP, may play a role. Twenty-two dogs underwent 1 h of coronary occlusion and 4 h of reperfusion: eight controls received no intervention, seven animals were preconditioned with four 5-min episodes of brief ischemia, and seven received MLA (35 micrograms/kg iv) 24 h previously. Collateral blood flow was measured by injection of radiolabeled microspheres, infarct size was delineated by tetrazolium staining, and myocardial 5'-NT activities were measured by quantifying the release of adenosine from AMP. Despite comparable values of collateral blood flow in all groups, infarct size was reduced in preconditioned and MLA-treated dogs vs. controls. In addition, 5'-NT activities were increased throughout the heart with preconditioning and MLA treatment. However, single and multivariate regression analyses revealed no correlation between infarct size and 5'-NT activities for either treatment group. In fact, in the preconditioned cohort, animals with the highest enzyme activities developed the largest infarcts. This dissociation between infarct size and 5'-NT suggests that increased activity of 5'-NT is not the mechanism by which preconditioning or MLA treatment protects the canine heart against infarction.

This article has been cited by other articles:

				L. Xi, F. Salloum, D. Tekin, N. C. Jarrett, and R. C. Kukreja Glycolipid RC-552 induces delayed preconditioning-like effect via iNOS-dependent pathway in mice Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2418 - H2424. [Abstract] [Full Text] [PDF]

				A. S.A. Abd-Elfattah, J.-H. Guo, S. P. Goa, G. A. Elliot, P. Weber, M. A. Mahgoub, R. Marktanner, and A. Mohamed Myocardial protection with monophosphoryl lipid-A against aortic cross clamping-induced global stunning Ann. Thorac. Surg., November 1, 1999; 68(5): 1954 - 1959. [Abstract] [Full Text] [PDF]

				L. Xi, N. C. Jarrett, M. L. Hess, and R. C. Kukreja Essential Role of Inducible Nitric Oxide Synthase in Monophosphoryl Lipid A–Induced Late Cardioprotection : Evidence From Pharmacological Inhibition and Gene Knockout Mice Circulation, April 27, 1999; 99(16): 2157 - 2163. [Abstract] [Full Text] [PDF]

				H. Yaoita, K. Ogawa, K. Maehara, and Y. Maruyama Attenuation of Ischemia/Reperfusion Injury in Rats by a Caspase Inhibitor Circulation, January 27, 1998; 97(3): 276 - 281. [Abstract] [Full Text] [PDF]

				K. Przyklenk, K. Hata, and R. A. Kloner Is Calcium a Mediator of Infarct Size Reduction With Preconditioning in Canine Myocardium? Circulation, August 19, 1997; 96(4): 1305 - 1312. [Abstract] [Full Text]